The use of antidementia therapy in non-dementia cognitive disorders associated with COVID-19
IntroductionThe new coronavirus infection causes severe damage to the human body. One of the most serious complication is cognitive impairment.According to a meta-analysis by Maxime Taquet et al. (2021), which assessed neurological and psychiatric outcomes among 236,379 patients diagnosed with COVID...
Saved in:
Published in | European psychiatry Vol. 66; no. S1; pp. S804 - S805 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Paris
Cambridge University Press
01.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!